Article Information
History
- September 30, 2024.
Article Versions
- Version 1 (August 31, 2024 - 10:36).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Lucas McCullum1,2,
- Samuel Mulder1,2,
- Natalie West1,2,
- Robert Aghoghovbia3,
- Alaa Mohamed Shawky Ali2,
- Hayden Scott1,2,
- Travis C. Salzillo4,
- Yao Ding4,
- Alex Dresner5,
- Ergys Subashi4,
- Dan Ma6,
- R. Jason Stafford7,
- Ken-Pin Hwang7 and
- Clifton D. Fuller2,*
- 1UT MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences, Houston, USA
- 2Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
- 3Morehouse School of Medicine, Atlanta, USA
- 4Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
- 5Philips Healthcare MR Oncology, Cleveland, Ohio, USA
- 6Department of Biomedical Engineering, Case Western Reserve University, Cleveland, Ohio, USA
- 7Department of Imaging Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
- ↵*Corresponding Author:
Clifton D. Fuller <cdfuller{at}mdanderson.org>
Posted September 30, 2024.
Technical Development and In Silico Implementation of SyntheticMR in Head and Neck Adaptive Radiation Therapy: A Prospective R-IDEAL Stage 0/1 Technology Development Report
